BETA


2022/2110(DEC) 2021 discharge: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead CONT STRUGARIU Ramona (icon: Renew Renew) ZDECHOVSKÝ Tomáš (icon: EPP EPP), MANDA Claudiu (icon: S&D S&D), EICKHOUT Bas (icon: Verts/ALE Verts/ALE), KUHS Joachim (icon: ID ID), CZARNECKI Ryszard (icon: ECR ECR), OMARJEE Younous (icon: GUE/NGL GUE/NGL)
Committee Opinion ENVI
Committee Opinion LIBE BRICMONT Saskia (icon: Verts/ALE Verts/ALE) José GUSMÃO (icon: GUE/NGL GUE/NGL), Ramona STRUGARIU (icon: RE RE)
Lead committee dossier:

Events

2023/09/29
   Final act published in Official Journal
2023/05/10
   EP - Results of vote in Parliament
2023/05/10
   EP - Decision by Parliament
Details

The European Parliament decided to grant discharge to the Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the financial year 2021 and to approve the closure of the accounts for that year.

Noting that the Court of Auditors stated that it had obtained reasonable assurance that the Centre's annual accounts for the financial year 2021 were reliable and that the underlying transactions were legal and regular, Parliament adopted, by 577 votes to 39 with 14 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.

Centre’s financial statements

The EMCDDA's final budget for 2021 was EUR 18 974 791, representing an increase of 5.13% compared to 2020.

Budgetary and financial management

Parliament appreciated the budget monitoring efforts made during the 2021 financial year, which resulted in a budget implementation rate of 100%, the same rate as in 2020. The payment appropriations execution rate was 96.35 %, representing an increase of 1.62 % compared to the previous year. It further noted with satisfaction that the implementation rate of payment appropriations carried over from 2020 to 2021 was 98.80 %.

Other observations

Parliament also made a series of observations concerning performance, digitalisation, staff, procurement and internal control.

In particular, they noted that:

- in 2021, most of the Centre’s performance indicators were achieved;

- the Centre’s management board adopted the second Roadmap 2025 as well as the Centre’s new business model that aims to further develop the Centre into a customer-focused and data-driven organisation;

- the Centre is a responsible party in numerous key actions of the EU Drugs Action Plan 2021-2025 approved by the Council of the European Union in 2021;

- the Centre released its first fully digital flagship publication with eight ‘responses miniguides’ addressing key public health challenges in the drugs field, the launch of a new online toolkit aiming to meet targets in certain health areas and the release of special reports on the threats to the Union of emerging drug developments in Afghanistan and Iran, and on the Balkan and southern trafficking routes into the Union;

- the Centre’s participation in drug related training events and capacity building was welcomed, managing to transfer its knowledge to over 870 professionals working in the drug field, representing an increase of almost 75 % compared to 2020;

- on 31 December 2021, the establishment plan was 96 % implemented, with seven officials and 66 temporary agents appointed out of seven officials and 69 temporary agents authorised under the Union budget (compared to 76 authorised posts in 2021 and in 2020). Gender and geographical balance should be ensured;

- the Centre should enhance the digitalisation of its staff management system in order to increase its efficiency;

- in terms of procurement execution, the 2021 procurement plan was successfully executed by the Centre with 98 negotiated procedures of a total value of EUR 1 556 147. The Centre should continue its progress towards digitalising its procurement procedures;

- the Centre performed an assessment of its internal control framework in 2021, concluding that all components are present and functioning, with some improvements advisable regarding ‘control environment’, ‘control activities’ and ‘information and communication’;

- a revised anti-fraud strategy was adopted in 2021, with three strategic objectives and an action plan to be implemented in 2022.

Documents
2023/05/09
   EP - Debate in Parliament
2023/04/03
   EP - Committee report tabled for plenary, single reading
Documents
2023/04/03
   EP - Committee report tabled for plenary
Documents
2023/03/22
   EP - Vote in committee
2023/03/01
   EP - Committee opinion
Documents
2023/02/21
   EP - Amendments tabled in committee
Documents
2023/02/13
   CSL - Supplementary non-legislative basic document
Documents
2023/01/20
   EP - Committee draft report
Documents
2022/10/27
   CofA - Court of Auditors: opinion, report
2022/10/10
   EP - BRICMONT Saskia (Verts/ALE) appointed as rapporteur in LIBE
2022/09/13
   EP - Committee referral announced in Parliament
2022/07/14
   EP - STRUGARIU Ramona (Renew) appointed as rapporteur in CONT
2022/06/23
   EC - Non-legislative basic document
2022/06/23
   EC - Non-legislative basic document published

Documents

Votes

Décharge 2021: Observatoire européen des drogues et des toxicomanies - A9-0107/2023 - Ramona Strugariu - Proposition de résolution #

2023/05/10 Outcome: +: 577, -: 39, 0: 14
DE FR ES PL RO IT NL PT BE CZ HU BG SE AT IE SK HR LT DK FI LV SI EL CY EE MT LU
Total
89
73
51
48
29
64
26
19
18
21
16
15
21
17
12
13
12
10
12
13
8
8
12
6
7
5
5
icon: PPE PPE
159

Hungary PPE

1

Denmark PPE

For (1)

1

Cyprus PPE

2

Estonia PPE

For (1)

1

Malta PPE

For (1)

1

Luxembourg PPE

2
icon: S&D S&D
132

Belgium S&D

2

Czechia S&D

For (1)

1

Lithuania S&D

2

Latvia S&D

2

Slovenia S&D

2

Greece S&D

1

Cyprus S&D

2

Estonia S&D

2

Luxembourg S&D

For (1)

1
icon: Renew Renew
89

Poland Renew

1

Italy Renew

2

Hungary Renew

1
3

Austria Renew

For (1)

1

Ireland Renew

2

Croatia Renew

For (1)

1

Lithuania Renew

1

Finland Renew

2

Latvia Renew

For (1)

1

Slovenia Renew

2

Greece Renew

1

Estonia Renew

3

Luxembourg Renew

2
icon: Verts/ALE Verts/ALE
68

Poland Verts/ALE

For (1)

1

Romania Verts/ALE

1

Italy Verts/ALE

3

Netherlands Verts/ALE

3

Portugal Verts/ALE

1

Belgium Verts/ALE

3

Czechia Verts/ALE

3

Sweden Verts/ALE

3

Austria Verts/ALE

3

Ireland Verts/ALE

2

Lithuania Verts/ALE

2

Denmark Verts/ALE

1

Finland Verts/ALE

3
icon: The Left The Left
34

Netherlands The Left

For (1)

1

Belgium The Left

For (1)

1

Czechia The Left

1

Sweden The Left

For (1)

1

Denmark The Left

1

Finland The Left

For (1)

1

Cyprus The Left

2
icon: ECR ECR
57

Germany ECR

1

Netherlands ECR

Against (1)

4

Bulgaria ECR

1

Sweden ECR

3

Slovakia ECR

For (1)

1

Croatia ECR

1

Lithuania ECR

1

Finland ECR

2

Latvia ECR

For (1)

1
icon: NI NI
36

Netherlands NI

Against (1)

1

Slovakia NI

Against (1)

2

Croatia NI

Against (1)

2

Latvia NI

1
icon: ID ID
55

Czechia ID

For (1)

Abstain (1)

2

Austria ID

3

Denmark ID

Against (1)

1

Estonia ID

Abstain (1)

1
AmendmentsDossier
8 2022/2110(DEC)
2023/01/18 LIBE 8 amendments...
source: 740.765

History

(these mark the time of scraping, not the official date of the change)

events/7
date
2023-09-29T00:00:00
type
Final act published in Official Journal
procedure/final
title
OJ L 242 29.09.2023, p. 0343
url
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2023:242:TOC
procedure/stage_reached
Old
Procedure completed, awaiting publication in Official Journal
New
Procedure completed
events/5
date
2023-05-10T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=59827&l=en title: Results of vote in Parliament
docs/7
date
2023-05-10T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2023-0151_EN.html title: T9-0151/2023
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the financial year 2021 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors stated that it had obtained reasonable assurance that the Centre's annual accounts for the financial year 2021 were reliable and that the underlying transactions were legal and regular, Parliament adopted, by 577 votes to 39 with 14 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Centre’s financial statements
  • The EMCDDA's final budget for 2021 was EUR 18 974 791, representing an increase of 5.13% compared to 2020.
  • Budgetary and financial management
  • Parliament appreciated the budget monitoring efforts made during the 2021 financial year, which resulted in a budget implementation rate of 100%, the same rate as in 2020. The payment appropriations execution rate was 96.35 %, representing an increase of 1.62 % compared to the previous year. It further noted with satisfaction that the implementation rate of payment appropriations carried over from 2020 to 2021 was 98.80 %.
  • Other observations
  • Parliament also made a series of observations concerning performance, digitalisation, staff, procurement and internal control.
  • In particular, they noted that:
  • - in 2021, most of the Centre’s performance indicators were achieved;
  • - the Centre’s management board adopted the second Roadmap 2025 as well as the Centre’s new business model that aims to further develop the Centre into a customer-focused and data-driven organisation;
  • - the Centre is a responsible party in numerous key actions of the EU Drugs Action Plan 2021-2025 approved by the Council of the European Union in 2021;
  • - the Centre released its first fully digital flagship publication with eight ‘responses miniguides’ addressing key public health challenges in the drugs field, the launch of a new online toolkit aiming to meet targets in certain health areas and the release of special reports on the threats to the Union of emerging drug developments in Afghanistan and Iran, and on the Balkan and southern trafficking routes into the Union;
  • - the Centre’s participation in drug related training events and capacity building was welcomed, managing to transfer its knowledge to over 870 professionals working in the drug field, representing an increase of almost 75 % compared to 2020;
  • - on 31 December 2021, the establishment plan was 96 % implemented, with seven officials and 66 temporary agents appointed out of seven officials and 69 temporary agents authorised under the Union budget (compared to 76 authorised posts in 2021 and in 2020). Gender and geographical balance should be ensured;
  • - the Centre should enhance the digitalisation of its staff management system in order to increase its efficiency;
  • - in terms of procurement execution, the 2021 procurement plan was successfully executed by the Centre with 98 negotiated procedures of a total value of EUR 1 556 147. The Centre should continue its progress towards digitalising its procurement procedures;
  • - the Centre performed an assessment of its internal control framework in 2021, concluding that all components are present and functioning, with some improvements advisable regarding ‘control environment’, ‘control activities’ and ‘information and communication’;
  • - a revised anti-fraud strategy was adopted in 2021, with three strategic objectives and an action plan to be implemented in 2022.
docs/7
date
2023-05-10T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2023-0151_EN.html title: T9-0151/2023
type
Text adopted by Parliament, single reading
body
EP
events/4/docs
  • url: https://www.europarl.europa.eu/doceo/document/CRE-9-2023-05-09-TOC_EN.html title: Debate in Parliament
events/5
date
2023-05-10T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2023-0151_EN.html title: T9-0151/2023
forecasts
  • date: 2023-05-10T00:00:00 title: Vote in plenary scheduled
procedure/stage_reached
Old
Awaiting Parliament's vote
New
Procedure completed, awaiting publication in Official Journal
events/4
date
2023-05-09T00:00:00
type
Debate in Parliament
body
EP
forecasts/0
date
2023-05-09T00:00:00
title
Debate in plenary scheduled
docs/6/docs/0/url
https://www.europarl.europa.eu/doceo/document/A-9-2023-0107_EN.html
events/3/docs/0/url
https://www.europarl.europa.eu/doceo/document/A-9-2023-0107_EN.html
docs/6
date
2023-04-03T00:00:00
docs
title: A9-0107/2023
type
Committee report tabled for plenary, single reading
body
EP
events/3/docs
  • title: A9-0107/2023
forecasts/0
date
2023-05-09T00:00:00
title
Debate in plenary scheduled
forecasts/0
date
2023-05-08T00:00:00
title
Indicative plenary sitting date
forecasts/1
date
2023-05-10T00:00:00
title
Vote in plenary scheduled
events/3
date
2023-04-03T00:00:00
type
Committee report tabled for plenary
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
events/2
date
2023-03-22T00:00:00
type
Vote in committee
body
EP
forecasts/0
date
2023-03-22T00:00:00
title
Vote scheduled in committee
procedure/Other legal basis
Rules of Procedure EP 159
docs/3
date
2023-02-13T00:00:00
docs
title: 06248/2023
type
Supplementary non-legislative basic document
body
CSL
docs/4
date
2023-03-01T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/LIBE-AD-739534_EN.html title: PE739.534
committee
LIBE
type
Committee opinion
body
EP
docs/3/docs/0/url
https://www.europarl.europa.eu/doceo/document/CONT-AM-742582_EN.html
docs/3
date
2023-02-21T00:00:00
docs
title: PE742.582
type
Amendments tabled in committee
body
EP
forecasts/0/date
Old
2023-03-23T00:00:00
New
2023-03-22T00:00:00
docs/2/docs/0/url
https://www.europarl.europa.eu/doceo/document/CONT-PR-737478_EN.html
docs/2
date
2023-01-20T00:00:00
docs
title: PE737.478
type
Committee draft report
body
EP
forecasts/1
date
2023-05-08T00:00:00
title
Indicative plenary sitting date
docs/1
date
2022-10-27T00:00:00
docs
type
Court of Auditors: opinion, report
body
CofA
committees/2/rapporteur
  • name: BRICMONT Saskia date: 2022-10-10T00:00:00 group: Group of the Greens/European Free Alliance abbr: Verts/ALE
commission
  • body: EC dg: Budget commissioner: HAHN Johannes
committees/1/opinion
False
events/1
date
2022-09-13T00:00:00
type
Committee referral announced in Parliament
body
EP
procedure/dossier_of_the_committee
  • CONT/9/09872
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting committee decision
committees/0/shadows/0
name
SARVAMAA Petri
group
Group of European People's Party
abbr
EPP
forecasts
  • date: 2023-03-23T00:00:00 title: Vote scheduled in committee
committees/0
type
Responsible Committee
body
EP
committee_full
Budgetary Control
committee
CONT
associated
False
rapporteur
name: STRUGARIU Ramona date: 2022-07-14T00:00:00 group: Renew Europe group abbr: Renew
shadows
committees/0
type
Responsible Committee
body
EP
committee_full
Budgetary Control
committee
CONT
associated
False
committees/1
Old
type
Committee Opinion
body
EP
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
associated
False
New
type
Committee Opinion
body
EP
committee_full
Environment, Public Health and Food Safety
committee
ENVI
associated
False
committees/2
Old
type
Committee Opinion
body
EP
committee_full
Environment, Public Health and Food Safety
committee
ENVI
associated
False
New
type
Committee Opinion
body
EP
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
associated
False